Group 1 - Hesai Technology (HSAI.US) shares rose 1.06% to $22.82 ahead of market opening [1] - Hesai announced a strategic partnership with Meituan's drone division, with its second-generation solid-state LiDAR FTX being designated for mass production by Meituan [1] - Huachuang Securities reported that Hesai, as a leader in the global LiDAR industry, is expected to benefit from the advancement of L2+/L3/L4 regulations, allowing it to capture market share both domestically and internationally [1] Group 2 - The robotics LiDAR industry presents significant growth potential, which could become a second growth curve for the company [1]

Core Viewpoint - Hesai Technology (HSAI.US) has announced a strategic partnership with Meituan's drone division, marking a significant milestone as its second-generation solid-state LiDAR, FTX, has been selected for mass production by Meituan [1] Group 1: Company Developments - Hesai's stock price increased by 1.06% to $22.82 in pre-market trading [1] - The company is recognized as a leader in the global LiDAR industry and is expected to benefit from the advancement of L2+/L3/L4 regulations, which may allow it to capture a larger market share both domestically and internationally [1] - The robotics LiDAR sector presents substantial growth potential, which could serve as a second growth curve for the company [1] Group 2: Financial Metrics - The total market capitalization of Hesai is approximately $3.526 billion [1] - The stock has a 52-week high of $30.85 and a low of $10.41, indicating significant volatility [1] - The current price-to-earnings ratio is not applicable due to reported losses, and the price-to-book ratio stands at 2.802 [1]

Group 1 - Haixi New Drug (02637) rose nearly 5%, being a commercial-stage pharmaceutical company with integrated R&D, production, and sales capabilities, and a pipeline of innovative drugs under development [1] - Paige Biopharma-B (02565) increased over 4.1%, with cornerstone investors holding a total of 9.5845 million H shares, accounting for approximately 3.43% of the company's total issued H shares [1] - Naxin Micro (02676) surged over 5% to reach a new high of 118.4 HKD, operating under a fabless model focused on chip R&D and design, outsourcing wafer manufacturing and most packaging testing [1] - Huaxin Building Materials (06655) rose 1.46%, with a major shareholder planning to increase its A-share holdings by no less than 200 million RMB and no more than 400 million RMB within six months [1] Group 2 - Dairy stocks saw an uptick, with Modern Farming (01117) rising 6.21% and Youran Dairy (09858) increasing 6.29%, following the Ministry of Commerce's announcement of temporary countervailing measures against EU dairy imports [2] - Gakos-B (01167) rose over 2.7% after announcing a collaboration with AstraZeneca on its self-developed Pan-KRAS inhibitor JAB-23E73 [2] - Junda Co. (02865) increased over 4.1% after announcing a strategic investment in Shangyi Optoelectronics, focusing on perovskite battery technology applications in space energy [2] - Qiming Medical-B (02500) rose nearly 6% after submitting all application materials for CE MDR certification of its Cardiovalve system in Europe [2] Group 3 - Brain Dynamics-B (06681) saw a slight increase of 0.32%, participating in a national major science and technology project focused on the prevention and treatment of cancer and cardiovascular diseases [3] - Hesai Technology (02525) rose over 3.3% after announcing a strategic partnership with Meituan drones for mass production of its second-generation solid-state lidar [4] Group 4 - Hut8 (HUT.US) continued to rise by 4.13%, with a total increase of 37% over three trading days, following an upgrade of its target price to 85 USD by StoneX [5] - Unusual Machines (UMAC.US) surged 9.24%, with a total increase of 45% over three trading days, after receiving a 3.75 million USD order from Performance Drone Works [5] - Hycroft Mining (HYMC.US) opened with a 10.69% increase, having risen 460% since September, due to successful exploration drilling confirming high-grade silver continuity [6] - Sony (SONY.US) rose 2.1% after acquiring a 41% stake in Peanuts Holdings for 630 million CAD, which holds the rights to the Peanuts comic [7] - Novo Nordisk (NVO.US) increased by 7.3% after the FDA approved its first oral GLP-1 weight loss drug, Wegovy, set to launch in January at a starting price of 149 USD per month [7] - ZIM Integrated Shipping Services (ZIM.US) rose 5.78% as the board evaluates multiple acquisition proposals from strategic investors [7]

Core Viewpoint - Hesai Technology has announced a strategic partnership with Meituan Drone, marking a significant step in the integration of lidar technology with low-altitude logistics scenarios [1] Group 1: Company Developments - Hesai Technology's second-generation solid-state lidar, FTX, has officially been selected for mass production by Meituan Drone [1] - This collaboration signifies a breakthrough in promoting the industrialization of the low-altitude economy through the combined efforts of both companies [1]